Videos de Experimentos Relacionados
Financiamiento de los NIH: ¿cómo será el futuro?
Science (New York, N.Y.)
|April 17, 2007
Resumen
No abstract available in PubMed .
Videos de Conceptos Relacionados
También podría leer
Artículos Relacionados
Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.
Ordenar por
Same author
A Phase I, Randomized, SAD, MAD, and PK Study of Risvodetinib in Older Adults and Parkinson's Disease.
Journal of Parkinson's disease·2024
Same author
The c-Abl inhibitor IkT-148009 suppresses neurodegeneration in mouse models of heritable and sporadic Parkinson's disease.
Science translational medicine·2023
Same author
Parkinson's Disease Modification Through Abl Kinase Inhibition: An Opportunity.
Movement disorders : official journal of the Movement Disorder Society·2021
Same author
Seeking progress in disease modification in Parkinson disease.
Parkinsonism & related disorders·2021
Same author
Viral-based rodent and nonhuman primate models of multiple system atrophy: Fidelity to the human disease.
Neurobiology of disease·2020
Same author
Preclinical pharmacokinetic evaluation to facilitate repurposing of tyrosine kinase inhibitors nilotinib and imatinib as antiviral agents.
BMC pharmacology & toxicology·2018
Same journal
Erratum for the Research Article "Detecting supramolecular organic nanoparticles during heat wave".
Science (New York, N.Y.)·2026